Kezar’s decision to terminate the PALIZADE IIb trial comes after it was placed on a clinical hold due to four patient deaths.

certain laboratory test abnormalities While the symptoms of drug-induced lupus are similar to those of systemic lupus, only rarely will any major organs be affected. It usually takes several months or ...

Three different versions of Alexandria Wingate appear in a trio of purple paintings the Baltimorean started while a fine art ...

The FDA has placed Kezar Life Sciences’ lupus trial on hold after the biotech flagged four deaths during the phase 2b study.

Earlier this month, Kezar Life Sciences announced that the mid-stage test of zetomipzomib in lupus nephritis had been placed ...

The campaign targets young Hispanic/Latina and Black/African American women, raising awareness about the symptoms of lupus and encouraging ... The Prevalence of Lupus Nephritis in the Hispanic ...

Kezar (KZR) is discontinuing development of its drug zetomipzomib for the treatment of lupus nephritis so it can focus on ...

The clinical hold doesn’t cover its drug’s Investigational New Drug application for autoimmune hepatitis, for which the Phase ...

Kezar Life Sciences said on Thursday it would terminate its mid-stage trial studying its experimental drug in patients with active lupus nephritis and focus on the development of the drug in ...

While GSK’s Benlysta (belimumab) and Aurinia’s Lupkynis (voclosporin) have been important advances in the treatment arsenal for lupus nephritis (LN), a serious complication of systemic lupus ...